Works by Gagnon, Marc-André

Results: 37

« J'entends parler de leurs intérêts les plus chers » : Alphonse-Télesphore Lépine et l'engagement électoral des Chevaliers du travail à Montréal (1888-1896).

Published in:

Labour / Travail, 2016, v. 78, p. 11, doi. 10.1353/llt.2016.0051

By:

Gagnon, Marc-André

Publication type:

Article

Les chemises bleues : Adrien Arcand, journaliste antisémite canadien-français.

Published in:

2013

By:

GAGNON, MARC-ANDRÉ

Publication type:

Book Review

Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health.

Published in:

Journal of Law, Medicine & Ethics, 2013, v. 41, n. 3, p. 571, doi. 10.1111/jlme.12066

By:

Gagnon, Marc-André

Publication type:

Article

Background Radiance Estimation for Gas Plume Quantification for Airborne Hyperspectral Thermal Imaging.

Published in:

Journal of Spectroscopy, 2016, p. 1, doi. 10.1155/2016/5428762

By:

Idoughi, Ramzi;
Vidal, Thomas H. G.;
Foucher, Pierre-Yves;
Gagnon, Marc-André;
Briottet, Xavier

Publication type:

Article

Beheading the Saint: Nationalism, Religion, and Secularism in Quebec.

Published in:

2016

By:

Gagnon, Marc-André

Publication type:

Book Review

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States.

Published in:

PLoS Medicine, 2008, v. 5, n. 1, p. e1, doi. 10.1371/journal.pmed.0050001

By:

Gagnon, Marc-André;
Lexchin, Joel

Publication type:

Article

Editorial: Current priorities in health research agendas: tensions between public and commercial interests in prioritizing biomedical, social, and environmental aspects of health.

Published in:

Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1391982

By:

García Carrillo, Mercedes;
Gagnon, Marc-André;
Blaustein, Matías

Publication type:

Article

Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada.

Published in:

Toxics, 2023, v. 11, n. 2, p. 121, doi. 10.3390/toxics11020121

By:

Bacon, Marie-Hélène;
Vandelac, Louise;
Gagnon, Marc-André;
Parent, Lise

Publication type:

Article

VACCINS : RECHERCHE PUBLIQUE, PROFITS PRIVÉS: Le monopole du secteur privé sur les vaccins contre la COVID-19 est un scandale auquel le Canada participe activement.

Published in:

Relations (00343781), 2021, n. 813, p. 6

By:

Gagnon, Marc-André

Publication type:

Article

The "pause" on the Canadian Task Force on Preventive Health Care is misguided.

Published in:

2025

By:

Grad, Roland;
Wittmer, René;
Bois, Geneviève;
Jen, Yun;
Gagnon, Marc-André

Publication type:

Letter

Le temps est venu d'améliorer la transparence à l'Agence de réglementation de la lutte antiparasitaire de Santé Canada.

Published in:

Canadian Medical Association Journal (CMAJ), 2024, v. 196, n. 6, p. E206, doi. 10.1503/cmaj.231089-f

By:

Gagnon, Marc-André;
Bacon, Marie-Hélène

Publication type:

Article

Time to improve transparency at Health Canada's Pest Management Regulatory Agency.

Published in:

Canadian Medical Association Journal (CMAJ), 2023, v. 195, n. 46, p. E1583, doi. 10.1503/cmaj.231089

By:

Gagnon, Marc-André;
Bacon, Marie-Hélène

Publication type:

Article

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study.

Published in:

Canadian Medical Association Journal (CMAJ), 2023, v. 195, n. 46, p. E1565, doi. 10.1503/cmaj.230841

By:

Grundy, Quinn;
Quanbury, Ashton;
Hart, Dana;
Chaudhry, Shanzeh;
Tavangar, Farideh;
Lexchin, Joel;
Gagnon, Marc-André;
Tadrous, Mina

Publication type:

Article

Médicaments : de la conception à la prescription.

Published in:

2011

By:

GAGNON, Marc-André

Publication type:

Book Review

Unveiling chemical industry secrets: Insights gleaned from scientific literatures that examine internal chemical corporate documents—A scoping review.

Published in:

2025

By:

Dong, Miaoran;
Gagnon, Marc-André

Publication type:

Literature Review

Le modèle de croissance anglo-saxon en théorie et en pratique. Analyse du régime de croissance américain.

Published in:

Cahiers de Recherche Sociologique, 2008, n. 45, p. 93, doi. 10.7202/1002501ar

By:

Gagnon, Marc-André

Publication type:

Article

Comparison between nuclear magnetic resonance profiling and the source/sink approach for characterizing drug diffusion in hydrogel matrices.

Published in:

Pharmaceutical Development & Technology, 2011, v. 16, n. 6, p. 651, doi. 10.3109/10837450.2010.502900

By:

Gagnon, Marc-André;
Lafleur, Michel

Publication type:

Article

Correction: Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.

Published in:

PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0296549

By:

Testoni, Federico E.;
Carrillo, Mercedes García;
Gagnon, Marc-André;
Rikap, Cecilia;
Blaustein, Matías

Publication type:

Article

NOTRE POISON QUOTIDIEN. LA RESPONSABILITÉ DE UINDUSTRIE CHIMIQUE DANS L'ÉPIDÉMIE DES MALADIES CHRONIQUES.

Published in:

Relations (00343781), 2012, n. 755, p. 40

By:

Gagnon, Marc-André

Publication type:

Article

Situer, définir, engager: aux origines des États généraux du Canada français (1961–1966).

Published in:

Quebec Studies, 2019, v. 67, p. 113, doi. 10.3828/qs.2019.8

By:

Gagnon, Marc-André

Publication type:

Article

Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.

Published in:

2019

By:

Gleeson, Deborah;
Lexchin, Joel;
Labonté, Ronald;
Townsend, Belinda;
Gagnon, Marc-André;
Kohler, Jillian;
Forman, Lisa;
Shadlen, Kenneth C.

Publication type:

journal article

Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016.

Published in:

2017

By:

Gagnon, Marc-André;
Volesky, Karena D.

Publication type:

journal article

The effect of buffering on oxyphenbutazone absorption kinetics and systemic availability.

Published in:

Biopharmaceutics & Drug Disposition, 1980, v. 1, n. 6, p. 307, doi. 10.1002/bdd.2510010603

By:

Ducal, Robert;
Dupuis, Claire;
Bertrand, Michel;
Gagnon, Marc-André

Publication type:

Article

Capital, Power and Knowledge According to Thorstein Veblen: Reinterpreting the Knowledge-Based Economy.

Published in:

Journal of Economic Issues, 2007, v. 41, n. 2, p. 593, doi. 10.1080/00213624.2007.11507049

By:

Gagnon, Marc-André

Publication type:

Article

Commentary: Which Principles Should Apply for a National Strategy on Rare Diseases?

Published in:

Healthcare Policy, 2024, v. 19, n. 4, p. 27, doi. 10.12927/hcpol.2024.27353

By:

GAGNON, MARC-ANDRÉ

Publication type:

Article

Commentary: Reconsidering Pharmaceutical Research and Development Investments.

Published in:

Healthcare Policy, 2023, v. 18, n. 3, p. 25, doi. 10.12927/hcpol.2023.27037

By:

GAGNON, MARC-ANDRÉ

Publication type:

Article

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Published in:

Healthcare Policy, 2016, v. 12, n. 1, p. 18

By:

MORGAN, STEVEN G.;
GAGNON, MARC-ANDRÉ;
MINTZES, BARBARA;
LEXCHIN, JOEL

Publication type:

Article

Trois types de stratégies des fabricants pour la fidélisation aux médicaments de marque.

Published in:

Healthcare Policy, 2014, v. 10, n. 2, p. 79

By:

PRÉMONT, MARIE-CLAUDE;
GAGNON, MARC-ANDRÉ

Publication type:

Article

Assessment, Intervention, and Training Needs of Service Providers for Children with Intellectual Disabilities or Autism Spectrum Disorders and Concurrent Problem Behaviours.

Published in:

Exceptionality Education International, 2015, v. 25, n. 2, p. 65, doi. 10.5206/eei.v25i2.7725

By:

Rivard, Mélina;
Morin, Diane;
Dionne, Carmen;
Mello, Catherine;
Gagnon, Marc-André

Publication type:

Article

Correction: Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.

Published in:

2021

By:

Testoni, Federico E.;
Carrillo, Mercedes García;
Gagnon, Marc-André;
Rikap, Cecilia;
Blaustein, Matías

Publication type:

Correction Notice

Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.

Published in:

PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0249661

By:

Testoni, Federico E.;
García Carrillo, Mercedes;
Gagnon, Marc-André;
Rikap, Cecilia;
Blaustein, Matías

Publication type:

Article

CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs.

Published in:

Globalization & Health, 2014, v. 10, n. 1, p. 1, doi. 10.1186/1744-8603-10-30

By:

Lexchin, Joel;
Gagnon, Marc-André

Publication type:

Article

Co-pay cards in Canada: Improving choice or institutionalizing bribes?

Published in:

2019

By:

Gagnon, Marc-André

Publication type:

journal article

Evaluating the effects of Quebec's private-public drug insurance system.

Published in:

2017

By:

Morgan, Steven G.;
Gagnon, Marc-André;
Charbonneau, Mathieu;
Vadeboncoeur, Alain

Publication type:

journal article

The role and impact of cost-sharing mechanisms for prescription drug coverage.

Published in:

2017

By:

Gagnon, Marc-André

Publication type:

journal article

Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-Industry-Funded Trials.

Published in:

International Journal of Health Policy & Management, 2024, v. 13, n. 1, p. 1, doi. 10.34172/ijhpm.2024.8239

By:

Lexchin, Joel;
Dong, Blue Miaoran;
Ramanathan, Aravind;
Gagnon, Marc-André

Publication type:

Article

Understanding the Battle for Universal Pharmacare in Canada.

Published in:

International Journal of Health Policy & Management, 2021, v. 10, n. 3, p. 168, doi. 10.34172/ijhpm.2020.40

By:

Gagnon, Marc-André

Publication type:

Article